Wuhan YZY Biopharma Co., Ltd.

SEHK:2496 Stock Report

Market Cap: HK$759.9m

Wuhan YZY Biopharma Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 2496?
Owner TypeNumber of SharesOwnership Percentage
General Public5,222,3052.69%
Institutions11,282,8355.82%
VC/PE Firms13,843,6697.14%
Employee Share Scheme16,792,7078.66%
Individual Insiders37,988,96319.6%
Public Companies51,241,78526.4%
Private Companies57,476,93629.7%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 20 shareholders own 97.31% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
26.4%
CSPC Pharmaceutical Group Limited
51,241,785HK$200.9m0%no data
10.5%
Qian Yuan
20,399,933HK$80.0m0%no data
8.66%
Wuhan YZY Biopharma Co., Ltd, ESOP
16,792,707HK$65.8m0%no data
7.14%
Tongde Qianyuan (Beijing) Investment Management Co., Ltd.
13,843,669HK$54.3m0%30.31%
5.99%
Nanjing Caizhi No. 2 Enterprise Management Partnership
11,620,412HK$45.6m0%no data
5.26%
Hongfeng Zhou
10,199,921HK$40.0m0%no data
4.27%
Hubei Science Technology Investment Group Co. Ltd
8,286,000HK$32.5m0%no data
4.08%
Long Star Growth Group Limited
7,916,510HK$31.0m0%no data
3.94%
Hainan Boyou Enterprise Management Consulting Center (Limited Partnership)
7,628,713HK$29.9m0%no data
3.71%
Guoxin Sichuang Investment Fund Management (Beijing) Co., Ltd.
7,196,835HK$28.2m0%no data
3.71%
Ningbo Meishan Bonded Port Area Guangrui Hongxiang Equity Investment Partnership (Limited Partnershi
7,196,835HK$28.2m0%no data
3.61%
Wuhan Optics Valley New Technology Industry Investment Co., Ltd.
7,000,000HK$27.4m0%no data
3.54%
Pengfei Zhou
6,869,744HK$26.9m0%no data
1.78%
Nanning Yaoyou Business Consulting Partnership Enterprise (Limited Partnership)
3,447,526HK$13.5m0%no data
1.57%
Gongqingcheng Huiyou Xingyao Phase Ii Equity Investment Partnership (Limited Partnership)
3,038,340HK$11.9m0%no data
1.39%
Wuhan Optics Valley Industrial Investment Co., Ltd.
2,686,000HK$10.5m0%no data
0.72%
Wuhan Optics Valley Growth Venture Capital Management Co., Ltd.
1,400,000HK$5.5m0%no data
0.69%
Chengdu Puhua Kaizhi Biotechnology Co., Ltd.
1,342,600HK$5.3m0%no data
0.19%
Hongwei Guo
370,087HK$1.5m0%no data
0.077%
Chen Linan
149,278HK$585.2k0%no data